Ocular Therapeutix Inc
NASDAQ:OCUL
Ocular Therapeutix Inc
Pre-Tax Income
Ocular Therapeutix Inc
Pre-Tax Income Peer Comparison
Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors
Company | Pre-Tax Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Ocular Therapeutix Inc
NASDAQ:OCUL
|
Pre-Tax Income
-$115.3m
|
CAGR 3-Years
4%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-21%
|
|
Johnson & Johnson
NYSE:JNJ
|
Pre-Tax Income
$20.1B
|
CAGR 3-Years
5%
|
CAGR 5-Years
3%
|
CAGR 10-Years
2%
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Pre-Tax Income
-$5.8B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Pfizer Inc
NYSE:PFE
|
Pre-Tax Income
-$1.8B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Merck & Co Inc
NYSE:MRK
|
Pre-Tax Income
$3.9B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-4%
|
|
Eli Lilly and Co
NYSE:LLY
|
Pre-Tax Income
$7.6B
|
CAGR 3-Years
2%
|
CAGR 5-Years
20%
|
CAGR 10-Years
5%
|
See Also
What is Ocular Therapeutix Inc's Pre-Tax Income?
Pre-Tax Income
-115.3m
USD
Based on the financial report for Mar 31, 2024, Ocular Therapeutix Inc's Pre-Tax Income amounts to -115.3m USD.
What is Ocular Therapeutix Inc's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 10Y
-21%
Over the last year, the Pre-Tax Income growth was -30%. The average annual Pre-Tax Income growth rates for Ocular Therapeutix Inc have been 4% over the past three years , -13% over the past five years , and -21% over the past ten years .